Clinical Trials Sponsored by Slb Pharma

Total 8534 results

Mexbrain
Slb Pharma

Not yet recruiting

Feasibility Pilot Study to Evaluate the Safety and Performance of the MEX-CD1 Medical Device in ACLF (MexACLF)

Multiple Organ Failure | Acute on Chronic Liver Failure

France
Vivisol
Slb Pharma

Recruiting

Oxygen Therapy Remote Monitoring in COPD Patients.

Chronic Obstructive Pulmonary Disease

France
ABEYE
Slb Pharma

Completed

Evaluation of the Performance and Safety of the Atoldys/ Lexilens Glasses Developed to Improve the Reading of Dyslexic Subjects

Dyslexia

France
Septodont
Slb Pharma

Completed

Endodontic Post-operative Pain Evaluation of Patients After Using Endomethasone N or Endomethasone SP (EndoPOP) (EndoPOP)

Root Canal Obturation

France
SpineVision
Slb Pharma

Recruiting

Safety and Performance of the SpineVision Posterior Fixation Systems in Thoracolumbar Spinal Treatment (FixedD3)

Intervertebral Disc Degeneration

France
Septodont
Slb Pharma

Active, not recruiting

Root Canal Obturation With a Ready-to-use Root Canal Sealer (PA1704) Versus BioRoot™ RCS: a Randomized Controlled Trial (OPTIFILL)

Root Canal Obturation

France, Belgium
Blueback
Slb Pharma

Completed

Evaluation of Performances and Safety of the Medical Device Blueback® Physio for Patients With Chronic Low Back Pain (ABC-TRACC)

Low Back Pain, Recurrent

France
Nutravalia
Slb Pharma

Completed

Effect of ANACA3 Slimming Gel on Loss of Abdominal and Thigh Circumferences in Healthy Volunteers

Overweight and Obesity

France
FH ORTHO
Slb Pharma

Recruiting

Performance and Safety Evaluation of the FHK®-CK Knee Prosthesis (FHK-CK)

Total Knee Arthroplasty

France
ACTEON Group
Slb Pharma

Completed

Efficacy of a Collagen Hemostatic Dressing After Tooth Extraction

Tooth Avulsion

France
ACTEON Group
Slb Pharma

Completed

Pain After Root Canal Obturation With Sealer Containing or Not 1% Enoxolone

Root Canal Obturation

France
ACTEON Group
Slb Pharma

Completed

Postoperative Pain After Root Canal Obturation With Sealer Containing Prednisolone.

Root Canal Obturation

France
Laboratoires Gilbert
Slb Pharma

Completed

Evaluation of the Safety and Performance of LiNiDERM® in the Prevention of Infant Diaper Rash

Diaper Rash

Poland
SATT Ouest Valorisation
Slb Pharma

Completed

Evaluation of the Performance and Safety of a Medical Device Developed to Improve the Reading of Dyslexic Patients (DysLight)

Dyslexia

France
Asten Sante
Slb Pharma; Withings; Nouvéal

Recruiting

Impact of Patient Involvement in Alerts Management of Telemonitoring CPAP

OSA

France
Vivisol
Slb Pharma; France Oxygène; MBar

Completed

Compliance of Long-term Home Non-invasive Ventilation for Patients With Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

France
Laboratoire de la Mer
Slb Pharma

Not yet recruiting

PMCF to Assess Real-life Usage Effectiveness, Safety and Patient Satisfaction of a Range of Hypertonic Seawater-based Decongestant Nasal Sprays

Allergic Rhinitis | URTI
Septodont
Rennes University Hospital; Slb Pharma

Completed

Gingival Displacement With RACESTYPTINE Solution and RACEGEL: a Prospective, Comparative Randomized Clinical Trial. (RETRACT)

Gingival Retraction Techniques

France
Dr. Schär AG / SPA
Slb Pharma

Recruiting

Low-Protein Diet With Low-Protein Foods Versus a LPD Without LP Foods in Patients With Chronic Kidney Disease (CKD)

Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease Stage 3B

France
Seven Dreamers Europe SAS
Slb Pharma; nastent.inc

Completed

Efficacy, Safety and Acceptability of Nastent™ in Snoring and Obstructive Sleep Apnea

Snoring | Obstructive Sleep Apnea

France
Slb Pharma
Université de Caen Normandie; Capital Innovation

Completed

Follow Fever to Decide

Body Temperature Changes

France
Evolucare Technologies
Assistance Publique - Hôpitaux de Paris; Slb Pharma; BPIfrance

Recruiting

OphtAI Diagnostic Performance Validation for Automated Screening of Eye Diseases (OPHTAI-EVAL)

Glaucoma | Age-Related Macular Degeneration | Diabetic Retinopathy | Diabetic Macular Edema | Age-related Maculopathy

France
Northumbria University
Nektium Pharma SL

Completed

Acute Dose-ranging Effects of Mango Leaf Extract (Zynamite® 15%) on Cognitive Function and Cerebral Blood Flow

Cognitive Change

United Kingdom
Nektium Pharma SL
Clínica Barem

Completed

Effects of a New Botanical Extracts Combination on Quality of Life in Menopausal Spanish Women

Quality of Life | Menopause | Dietary Supplements

Spain
Catalysis SL
Atika Pharma S.L.

Recruiting

Evaluation Of The Efficacy Of The Combination Of GLIZIGEN® Oral Solution 1/Day And Vaginal Gel 1/Night For 2 Months In Patients With Cervical Intraepithelial Neoplasia Grade 1 (LSIL/CIN-1) Caused By High-Risk Human Papillomavirus (HPV-AR)

Papilloma Viral Infection | CIN1 | LSIL, Low Grade Squamous Intraepithelial Lesion

Spain
Northumbria University
Nektium Pharma SL

Completed

Acute Effects of Mango Leaf Extract (Zynamite®) on Cognitive Function, Mood and Stress (MLE-ZYN)

Stress | Cognitive Change

United Kingdom
Traslational Cancer Drugs Pharma, SL

Completed

Study of Intravenous TCD-717 in Patients With Advanced Solid Tumors

Advanced Solid Tumors

United States
FSD Pharma, Inc.
Lucid Psycheceuticals Inc. (sub of FSD Pharma, Inc.)

Completed

Evaluating the Safety, Tolerability, Pharmacokinetics, and Effect of Food of Lucid-21-302 in Healthy Volunteers

Healthy Participants

Canada
Slb Pharma
La Région Basse-Normandie; Université de Caen Normandie; European Regional Development...

Recruiting

Upper Limb Rehabilitation Using Virtual Reality in Children With Cerebral Palsy (RV-REEDUC) (RV-REEDUC)

Brain Diseases | Cerebral Palsy

France
Groupe Medical de Pneumologie, Polyclinique Saint-Laurent
ResMed; Slb Pharma; VitalAire; Regional Health Agency - Brittany

Completed

Benefit of Cheyne-Stokes Respiration Remote Monitoring in CPAP-treated Patients With Obstructive Sleep Apnea to Detect Early Events of Heart Failure.

Obstructive Sleep Apnea

France
R-Pharm
Covance; Cromos Pharma LLC

Withdrawn

Study of the Efficacy and Safety of a Single Administration of Olokizumab vs. Placebo in Addition to Standard Treatment in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19).

COVID-19
UCB BIOSCIENCES, Inc.
R-Pharm

Terminated

Open-label Study to Assess the Safety and Efficacy of CDP6038 (Olokizumab) in Patients Who Completed RA0056

Rheumatoid Arthritis

United States, Belgium, United Kingdom
AJU Pharm Co., Ltd.
OM Pharma SA

Recruiting

The Efficacy and Safety of OM-89 in Patients With Recurrent Chronic Prostatitis/Chronic Pelvic Pain Syndrome

Chronic Prostatitis With Chronic Pelvic Pain Syndrome | Chronic Prostatitis | Chronic Pelvic Pain Syndrome

Korea, Republic of
UCB BIOSCIENCES, Inc.
R-Pharm

Terminated

The Long-term Safety and Efficacy of CDP6038 (Olokizumab) With Active Rheumatoid Arthritis

Rheumatoid Arthritis

Japan, Korea, Republic of, Taiwan
Yuria-Pharm
Pharmaxi LLC

Completed

Epidemiological Study of the COVID-2019 in Participating Organizations.

Covid19

Ukraine
Neurovoxel SLP

Completed

Functional MRI Study of Vibrotactile Stimulation Effects in Fibromyalgia

Fibromyalgia

Spain
SAb Biotherapeutics, Inc.

Recruiting

A Study to Assess the Safety of SAB-176 to Prevent the Flu, Given IM in Healthy Adults Compared With Placebo (SAB-176-103)

PHA1A

United States
Igen BioLab SLU

Completed

Evaluation of the Quality of Life of Patients With Metastatic Non-small Cell Lung Cancer With Supplementary Therapy With IGEN-0206

Non-small Cell Lung Cancer Metastatic | Quality of Life of Patients

Spain
SAb Biotherapeutics, Inc.

Active, not recruiting

Safety, Tolerability, and Pharmacokinetics of SAB-176 in Healthy Participants

Influenza | Influenza Type B | Influenza Type A

United States
PT Sydna Farma
PT Pharma Metric Labs

Completed

Bioequivalence Study of Cyproterone Acetate and Ethinyl Estradiol in Healthy Female Volunteers

Drug Use

Indonesia
Monash University
Caring Pharmacy; Bionime Corporation; Tigas Pharma

Active, not recruiting

Prevention and Treatment of Diabetes in Adults

PreDiabetes

Malaysia
UCB Biopharma S.P.R.L.
Pharm Research Associates (UK) Ltd.

Completed

Study to Look at How Effective Briviact is as add-on Treatment for Patients With Epilepsy With Partial Onset Seizures (BASE)

Epilepsy With POS With or Without Secondary Generalization

Denmark, Germany, Hungary, Ireland, Italy, Netherlands, Norway, Spain, United Kingdom
UCB Pharma SA

Completed

Open-label Long-term Study of Adjunctive Brivaracetam in Pediatric Subjects With Epilepsy

Epilepsy

United States, Belgium, Czechia, France, Germany, Hungary, Ireland, Italy, Mexico, Poland, Spain, United Kingdom
UCB Pharma SA

Completed

Study With Subjects 18-65 Years Old With Partial Onset Seizures Who Are Currently Taking Levetiracetam

Epilepsy, Partial

Canada, United States
Vifor Pharma, Inc.

Terminated

Pharmacodynamic & Safety of Patiromer in Children & Adolescents (2-<18 Yrs) With Chronic Kidney Disease and Hyperkalemia (EMERALD)

Hyperkalemia

United States, Bulgaria, Canada, Georgia, Germany, Poland, Ukraine
UCB Pharma SA

Completed

Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Epilepsy

Belgium, Finland, France, Germany, Hungary, India, Italy, Netherlands, Poland, Spain, Switzerland, United Kingdom
UCB Pharma SA

Completed

Long Term Follow up Treatment With Levetiracetam in Subjects of 4 Years and Older With Generalized Epilepsy

Generalized Epilepsy
UCB Pharma SA

Completed

Prevention of Asthma With Levocetirizine 18 Month Treatment in Infants (12 - 24 Months) Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and/or House Dust Mite (HDM)

Dermatitis, Atopic
UCB Pharma SA

Completed

A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425] (PRECiSE 3)

Crohn's Disease

United States, Australia, Austria, Belarus, Belgium, Bulgaria, Czechia, Denmark, Estonia, Germany, Hungary, Israel, Italy, New Zealand, Norway, Poland, Russian Federation, Serbia, Singapore, Slovenia, South Africa, Spain, Ukraine, Canada and more
NicOx
Theradis pharma; Iris Pharma

Withdrawn

Efficacy and Safety of Iota-Carrageenan Eye Drops (NCX-4240) (Goldeneye)

Adenoviral Conjunctivitis

Spain

3

Subscribe